BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2665219)

  • 21. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strength of HLA-A, HLA-B, and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Collaborative Transplant Study.
    Opelz G
    Transpl Int; 1992; 5 Suppl 1():S621-4. PubMed ID: 14628741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up in London Transplant Group recipients of cadaver renal allografts. The influence of HLA matching on transplant outcome.
    Festenstein H; Doyle P; Holmes J
    N Engl J Med; 1986 Jan; 314(1):7-14. PubMed ID: 3510010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of HLA cross-reactive group matching on graft survival in deceased donor kidney recipients.
    Lazda VA; Mozes MF
    Transplant Proc; 2005 Mar; 37(2):661-3. PubMed ID: 15848493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E; Berthoux F; Acquart S; Lepetit JC
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus and HLA-A, B, and DR locus interactions: impact on renal transplant graft survival.
    Schnitzler MA; Woodward RS; Brennan DC; Phelan DL; Spitznagel EL; Boxerman SB; Dunagan WC; Bailey TC
    Am J Kidney Dis; 1997 Dec; 30(6):766-71. PubMed ID: 9398119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations.
    Quantz MA; Bennett LE; Meyer DM; Novick RJ
    J Heart Lung Transplant; 2000 May; 19(5):473-9. PubMed ID: 10808155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between skin cancer and HLA antigens in renal-transplant recipients.
    Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
    N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cadaver-donor renal retransplants.
    Cho YW; Cecka JM
    Clin Transpl; 1993; ():469-84. PubMed ID: 7918181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Balan V; Ruppert K; Demetris AJ; Ledneva T; Duquesnoy RJ; Detre KM; Wei YL; Rakela J; Schafer DF; Roberts JP; Everhart JE; Wiesner RH
    Hepatology; 2008 Sep; 48(3):878-88. PubMed ID: 18752327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR associated immune responsiveness.
    Cook DJ
    Clin Transpl; 1986; ():247-56. PubMed ID: 3154411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients.
    Hata Y; Cecka JM; Takemoto S; Ozawa M; Cho YW; Terasaki PI
    Transplantation; 1998 Jan; 65(2):208-12. PubMed ID: 9458016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Success rate and impact of HLA matching on kidney graft survival in highly immunized recipients. Collaborative Transplant Study.
    Opelz G
    Transpl Int; 1992; 5 Suppl 1():S601-3. PubMed ID: 14628740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
    Opelz G; Döhler B; Middleton D; Süsal C;
    Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of HLA-DR matching in polytransfused cadaveric kidney transplant recipients. A prospective one-center study.
    Vanrenterghem Y; Vandeputte I; Lerut T; Roels L; Gruwez J; Michielsen P
    Transplantation; 1983 Oct; 36(4):384-7. PubMed ID: 6353705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.